Ftse Mib
32.665,21
-2,81%
DAX
18.002,02
-1,43%
S&P 500
5.431,60
-0,04%
NASDAQ
17.688,88
0,12%
Bitcoin
66.010,21
-1,12%
Registration Strip Icon for charts Registrati per grafici in tempo reale, strumenti di analisi e prezzi.
Registrati

Quotazioni in diretta

Non abbiamo trovato risultati per:
Assicurati di aver scritto correttamente o prova ad allargare la ricerca.

Più Attivi

Toplist

Sembra che tu non sia connesso.
Clicca il pulsante qui sotto per accedere e visualizzare la tua cronologia recente.

Registrati

Sei già registrato? Accedi

Pepperstone

Inizia Ora

Pepperstone
Home Investire Azioni U.S.A. NASDAQ Astria Therapeutics Inc (ATXS) Astria Therapeutics Inc (ATXS) Notizie

Astria Therapeutics Inc

ATXS
9,15
-0,02 (-0,22%)
Dopo l'orario di negoziazione
Ultimo aggiornamento: 22:07:02
Dati in Delay di 15 minuti
Borsa: NASDAQ
Tipo: Azione
Valuta: USD

Ultime notizie

Data Ora Fonte Titolo
06/6/202422:07EDGAR2Form 4 - Statement of changes in beneficial ownership of..
06/6/202422:06EDGAR2Form 4 - Statement of changes in beneficial ownership of..
06/6/202422:06EDGAR2Form 4 - Statement of changes in beneficial ownership of..
06/6/202422:05EDGAR2Form 4 - Statement of changes in beneficial ownership of..
06/6/202422:05EDGAR2Form 8-K - Current report
04/6/202422:10BWAstria Therapeutics Announces Inducement Grants Under Nasdaq..
30/5/202414:00BWAstria Therapeutics to Present at Upcoming Jefferies..
24/5/202414:00BWAstria Therapeutics to Present at Upcoming Eastern Allergy..
23/5/202414:00BWAstria Therapeutics to Present at Upcoming European Academy..
09/5/202422:10BWAstria Therapeutics Reports First Quarter 2024 Financial..
09/5/202422:01EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
08/5/202414:00BWAstria Therapeutics to Present at Upcoming Society for..
02/5/202422:00BWAstria Therapeutics Announces Inducement Grants Under Nasdaq..
09/4/202414:00BWAstria Therapeutics Appoints Sunil Agarwal to Its Board of..
03/4/202422:10BWAstria Therapeutics Announces Inducement Grants Under Nasdaq..
25/3/202412:30BWAstria Therapeutics Announces Positive Initial..
05/3/202422:10BWAstria Therapeutics Announces Inducement Grants Under Nasdaq..
04/3/202423:22EDGAR2Form 8-K - Current report
04/3/202423:20EDGAR2Form 424B5 - Prospectus [Rule 424(b)(5)]
04/3/202422:10BWAstria Therapeutics Reports Fourth Quarter and Full Year..
04/3/202422:02EDGAR2Form 10-K - Annual report [Section 13 and 15(d), not S-K..
20/2/202414:00BWAstria Therapeutics to Present at Upcoming American Academy..
14/2/202421:48EDGAR2Form SC 13G/A - Statement of acquisition of beneficial..
14/2/202421:00EDGAR2Form SC 13G/A - Statement of acquisition of beneficial..
14/2/202414:36EDGAR2Form SC 13G/A - Statement of acquisition of beneficial..
12/2/202422:06EDGAR2Form 4 - Statement of changes in beneficial ownership of..
12/2/202422:06EDGAR2Form 4 - Statement of changes in beneficial ownership of..
12/2/202422:05EDGAR2Form 4 - Statement of changes in beneficial ownership of..
12/2/202422:05EDGAR2Form 4 - Statement of changes in beneficial ownership of..
12/2/202422:05EDGAR2Form 4 - Statement of changes in beneficial ownership of..
12/2/202422:05EDGAR2Form 4 - Statement of changes in beneficial ownership of..
06/2/202414:00BWAstria Therapeutics to Present at Upcoming Oppenheimer 34th..
05/2/202422:00BWAstria Therapeutics Announces Inducement Grants Under Nasdaq..
31/1/202415:00EDGAR2Form 8-K - Current report
31/1/202414:59EDGAR2Form 424B5 - Prospectus [Rule 424(b)(5)]
30/1/202423:03EDGAR2Form 4 - Statement of changes in beneficial ownership of..
30/1/202415:08BWAstria Therapeutics Announces Pricing of $125 Million..
30/1/202412:01EDGAR2Form 8-K - Current report
29/1/202422:39EDGAR2Form 144 - Report of proposed sale of securities
16/1/202422:18EDGAR2Form SC 13G - Statement of acquisition of beneficial..
05/1/202414:30EDGAR2Form 8-K - Current report
02/1/202422:16EDGAR2Form SC 13G - Statement of acquisition of beneficial..
02/1/202406:15EDGAR2Form EFFECT - Notice of Effectiveness
28/12/202320:09EDGAR2Form S-3/A - Registration statement under Securities Act of..
20/12/202322:30EDGAR2Form 8-K - Current report
15/12/202314:30EDGAR2Form S-3 - Registration statement under Securities Act of..
04/12/202322:00BWAstria Therapeutics Announces Inducement Grants Under Nasdaq..
27/11/202314:00BWAstria Therapeutics to Present STAR-0215 Data at the 2023..
21/11/202314:00BWAstria Therapeutics to Present at Upcoming 6th Annual..
13/11/202322:02EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Apertura: 9,04 Min: 9,00 Max: 9,23
Chiusura: 9,17

La tua Cronologia

NASDAQ
ATXS
Astria Therapeutics
Delayed Upgrade Clock

Il sito ADVFN Italia è stato realizzato ed è gestito da PRODESFIN su licenza di ADVFN PLC.

PER CONTATTI E PUBBLICITA' SUL SITO CLICCARE QUI

Accedendo ai servizi offerti da ADVFN, ne si accettano le condizioni generali Termini & Condizioni

ADVFN Network